Regeneron Pharmaceuticals (REGN) has a market capitalization of $59.8B, based on 105.99M shares at a price of $564.63 (down 0.8% on Friday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
October 2025 | $564.63 | 9,823,600 | 105,987,444 | $59,843,690,505.72 |
September 2025 | $562.27 | 22,624,700 | 108,600,000 | $61,062,522,000.00 |
August 2025 | $580.70 | 21,419,400 | 108,600,000 | $63,064,020,000.00 |
July 2025 | $544.63 | 19,653,100 | 108,600,000 | $59,147,143,800.00 |
June 2025 | $524.20 | 27,780,600 | 108,600,000 | $56,928,554,400.00 |
May 2025 | $489.54 | 31,067,600 | 108,600,000 | $53,163,685,620.00 |
April 2025 | $596.97 | 25,663,600 | 108,600,000 | $64,830,963,720.00 |
March 2025 | $632.33 | 20,912,300 | 111,200,000 | $70,315,563,040.00 |
February 2025 | $696.65 | 17,887,000 | 111,200,000 | $77,467,635,680.00 |
January 2025 | $670.11 | 17,766,800 | 111,200,000 | $74,515,920,640.00 |
December 2024 | $709.29 | 18,051,400 | 113,800,000 | $80,717,122,340.00 |
November 2024 | $747.02 | 16,783,800 | 113,800,000 | $85,010,591,500.00 |
October 2024 | $834.62 | 17,457,700 | 113,800,000 | $94,979,983,600.00 |
September 2024 | $1,046.75 | 12,689,200 | 116,200,000 | $121,632,652,120.00 |
August 2024 | $1,179.63 | 10,420,300 | 116,200,000 | $137,073,331,360.00 |
July 2024 | $1,074.58 | 8,543,300 | 116,200,000 | $124,866,567,840.00 |
June 2024 | $1,046.54 | 9,285,600 | 115,400,000 | $120,771,119,900.00 |
May 2024 | $975.98 | 9,455,700 | 115,400,000 | $112,627,630,400.00 |
April 2024 | $886.86 | 10,148,700 | 115,400,000 | $102,343,413,200.00 |
March 2024 | $958.38 | 8,523,900 | 115,100,000 | $110,309,699,140.00 |
February 2024 | $961.97 | 10,253,800 | 115,100,000 | $110,722,286,600.00 |
January 2024 | $938.76 | 11,857,900 | 115,100,000 | $108,050,769,560.00 |
December 2023 | $874.54 | 12,741,300 | 113,800,000 | $99,522,743,040.00 |
November 2023 | $820.29 | 11,110,200 | 113,800,000 | $93,349,388,920.00 |
October 2023 | $776.56 | 8,722,000 | 113,800,000 | $88,372,630,420.00 |
